27.08.2010 • NewsDSMPeopleSchering

DSM Appoints New Director for Strategy and Acquisitions

New senior vice president in the corporate strategy & acquisitions department -...
New senior vice president in the corporate strategy & acquisitions department - Karin Dorrepaal

Royal DSM, the global life sciences and materials sciences company headquartered in the Netherlands, today announces the following:

Karin Dorrepaal (1961) will join DSM as senior vice president in the corporate strategy & acquisitions department, as of Sept. 1, reporting to Hein Schreuder.

At the end of 2011 Karin is to succeed Hein Schreuder (1951), at present executive vice president corporate strategy & acquisitions, reporting to Feike Sijbesma, CEO and chairman of the managing board.

Karin, a dutch national, has had several non executive roles since leaving the executive board of Schering in Berlin. Within the Schering board Karin was responsible for the business diagnostic imaging as well as the global supply chain and procurement. The supply chain activities included responsibility for chemical and pharmaceutical production, operations and related systems. Prior to joining Schering Karin was with Booz Allen & Hamilton (now Booz & Co.) for 14 years, where she was a leader of the life science practice. Karin Dorrepaal holds a PhD in Medicine as well as an MBA.

Her very strong external network within the industry will give Karin an excellent starting position to impact the strategic course of DSM.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.